Lifecore Biomedical (LFCR) Competitors $6.83 +0.23 (+3.48%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$6.75 -0.08 (-1.17%) As of 03/27/2025 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFCR vs. RCUS, VIR, RCKT, COLL, XNCR, REPL, PAHC, DAWN, ZYME, and EOLSShould you be buying Lifecore Biomedical stock or one of its competitors? The main competitors of Lifecore Biomedical include Arcus Biosciences (RCUS), Vir Biotechnology (VIR), Rocket Pharmaceuticals (RCKT), Collegium Pharmaceutical (COLL), Xencor (XNCR), Replimune Group (REPL), Phibro Animal Health (PAHC), Day One Biopharmaceuticals (DAWN), Zymeworks (ZYME), and Evolus (EOLS). These companies are all part of the "pharmaceutical products" industry. Lifecore Biomedical vs. Arcus Biosciences Vir Biotechnology Rocket Pharmaceuticals Collegium Pharmaceutical Xencor Replimune Group Phibro Animal Health Day One Biopharmaceuticals Zymeworks Evolus Lifecore Biomedical (NASDAQ:LFCR) and Arcus Biosciences (NYSE:RCUS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, community ranking, risk, valuation and dividends. Which has stronger earnings & valuation, LFCR or RCUS? Lifecore Biomedical has higher earnings, but lower revenue than Arcus Biosciences. Lifecore Biomedical is trading at a lower price-to-earnings ratio than Arcus Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifecore Biomedical$130.86M1.93$12.01M-$0.56-12.20Arcus Biosciences$258M3.45-$307M-$3.10-2.73 Which has more volatility & risk, LFCR or RCUS? Lifecore Biomedical has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Arcus Biosciences has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500. Do institutionals and insiders believe in LFCR or RCUS? 83.4% of Lifecore Biomedical shares are held by institutional investors. Comparatively, 92.9% of Arcus Biosciences shares are held by institutional investors. 32.2% of Lifecore Biomedical shares are held by company insiders. Comparatively, 12.3% of Arcus Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to LFCR or RCUS? In the previous week, Arcus Biosciences had 4 more articles in the media than Lifecore Biomedical. MarketBeat recorded 7 mentions for Arcus Biosciences and 3 mentions for Lifecore Biomedical. Lifecore Biomedical's average media sentiment score of 1.18 beat Arcus Biosciences' score of 0.11 indicating that Lifecore Biomedical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifecore Biomedical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Arcus Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is LFCR or RCUS more profitable? Lifecore Biomedical has a net margin of -12.52% compared to Arcus Biosciences' net margin of -102.66%. Arcus Biosciences' return on equity of -45.59% beat Lifecore Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Lifecore Biomedical-12.52% -315.23% -12.74% Arcus Biosciences -102.66%-45.59%-22.38% Do analysts rate LFCR or RCUS? Lifecore Biomedical presently has a consensus target price of $8.00, suggesting a potential upside of 17.13%. Arcus Biosciences has a consensus target price of $30.25, suggesting a potential upside of 256.97%. Given Arcus Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Arcus Biosciences is more favorable than Lifecore Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifecore Biomedical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Arcus Biosciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in LFCR or RCUS? Arcus Biosciences received 193 more outperform votes than Lifecore Biomedical when rated by MarketBeat users. Likewise, 65.33% of users gave Arcus Biosciences an outperform vote while only 25.00% of users gave Lifecore Biomedical an outperform vote. CompanyUnderperformOutperformLifecore BiomedicalOutperform Votes325.00% Underperform Votes975.00% Arcus BiosciencesOutperform Votes19665.33% Underperform Votes10434.67% SummaryArcus Biosciences beats Lifecore Biomedical on 13 of the 19 factors compared between the two stocks. Remove Ads Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFCR vs. The Competition Export to ExcelMetricLifecore BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$252.88M$6.91B$5.64B$8.06BDividend YieldN/A2.73%4.57%4.01%P/E Ratio-12.207.2023.1319.03Price / Sales1.93226.01383.8993.17Price / CashN/A65.6738.1634.64Price / Book18.466.476.944.33Net Income$12.01M$141.90M$3.20B$247.06M7 Day Performance4.27%-3.20%-2.32%-0.37%1 Month Performance16.95%-5.63%2.84%-3.85%1 Year Performance28.63%-7.47%10.75%1.27% Lifecore Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFCRLifecore Biomedical1.5654 of 5 stars$6.83+3.5%$8.00+17.1%+32.1%$252.88M$130.86M-12.20690RCUSArcus Biosciences2.332 of 5 stars$9.15-2.0%$30.25+230.5%-53.5%$962.43M$258M-2.91500Gap DownVIRVir Biotechnology3.6132 of 5 stars$7.01-2.0%$35.67+408.8%-34.0%$961.37M$63.71M-1.79580RCKTRocket Pharmaceuticals4.671 of 5 stars$8.83+0.8%$43.00+387.0%-71.1%$941.54MN/A-3.21240Positive NewsCOLLCollegium Pharmaceutical4.0812 of 5 stars$29.67+0.7%$43.60+46.9%-27.7%$934.19M$631.45M12.79210Analyst RevisionXNCRXencor3.4825 of 5 stars$12.98+1.7%$34.38+164.8%-48.7%$914.60M$110.49M-4.06280REPLReplimune Group3.8551 of 5 stars$11.78+1.1%$19.43+64.9%+26.7%$907.24MN/A-3.84210Positive NewsPAHCPhibro Animal Health3.9534 of 5 stars$21.85+2.8%$21.00-3.9%+66.0%$884.99M$1.11B45.521,860Analyst DowngradeShort Interest ↓Positive NewsDAWNDay One Biopharmaceuticals2.9913 of 5 stars$8.67+6.8%$34.57+298.7%-48.1%$878.75M$131.16M-8.4260Analyst ForecastZYMEZymeworks2.6648 of 5 stars$12.58+2.7%$21.00+66.9%+21.5%$875.28M$76.30M-8.39460Insider TradePositive NewsEOLSEvolus3.9948 of 5 stars$13.59+3.0%$24.67+81.5%-12.6%$864.15M$266.27M-14.93170 Remove Ads Related Companies and Tools Related Companies Arcus Biosciences Competitors Vir Biotechnology Competitors Rocket Pharmaceuticals Competitors Collegium Pharmaceutical Competitors Xencor Competitors Replimune Group Competitors Phibro Animal Health Competitors Day One Biopharmaceuticals Competitors Zymeworks Competitors Evolus Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFCR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LFCR Stock Free LFCR Stock Alerts